Knight Therapeutics Inc. (TSX: GUD)
Canada
· Delayed Price · Currency is CAD 5.73
+0.02 (0.35%)
Jul 19, 2024, 4:00 PM EDT
Knight Therapeutics Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 332.21 | 328.2 | 293.56 | 243.48 | 199.52 | 47.46 | Upgrade
|
| Revenue Growth (YoY) | 6.36% | 11.80% | 20.57% | 22.03% | 320.39% | 279.69% | Upgrade
|
| Cost of Revenue | 178.62 | 175.55 | 155.5 | 128.07 | 117.83 | 20.54 | Upgrade
|
| Gross Profit | 153.59 | 152.65 | 138.06 | 115.41 | 81.69 | 26.92 | Upgrade
|
| Selling, General & Admin | 87.11 | 83.69 | 88.62 | 74.38 | 70.74 | 24.23 | Upgrade
|
| Research & Development | 18.34 | 17.55 | 14.76 | 12.69 | 11.73 | 3.91 | Upgrade
|
| Depreciation & Amortization | 44.74 | 45.04 | 51.74 | 41.18 | 25.54 | 3.41 | Upgrade
|
| Operating Expenses | 150.19 | 146.28 | 155.12 | 128.24 | 108 | 31.56 | Upgrade
|
| Operating Income | 3.4 | 6.37 | -17.06 | -12.83 | -26.31 | -4.64 | Upgrade
|
| Interest Expense | -12.27 | -12.49 | -6.6 | -3.62 | -3.4 | -0.37 | Upgrade
|
| Interest & Investment Income | 11.86 | 12.58 | 10.63 | 7.38 | 14.32 | 23.54 | Upgrade
|
| Net Interest Expenses | -0.41 | 0.09 | 4.03 | 3.76 | 10.92 | 23.17 | Upgrade
|
| Income (Loss) On Equity Investments | - | - | - | - | - | 0.91 | Upgrade
|
| Currency Exchange Gain (Loss) | -13.31 | -15.17 | 7.44 | -3.74 | -14.16 | -1.39 | Upgrade
|
| Other Non Operating Income (Expenses) | -7.06 | -7.32 | -22.68 | 19.07 | 60.3 | 17.15 | Upgrade
|
| EBT Excluding Unusual Items | -17.38 | -16.03 | -28.27 | 6.27 | 30.76 | 35.2 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -3.69 | -8.02 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 2.95 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.42 | - | - | - | 4.17 | - | Upgrade
|
| Asset Writedown | -9.26 | -9.26 | -23.98 | - | -0.66 | -4.23 | Upgrade
|
| Other Unusual Items | 6.87 | 3.3 | 8.29 | 0.42 | -1.44 | -0.18 | Upgrade
|
| Pretax Income | -24.19 | -21.99 | -43.96 | 6.69 | 32.09 | 22.78 | Upgrade
|
| Income Tax Expense | -6.74 | -5.15 | -14.07 | -8.99 | 0.33 | 4.75 | Upgrade
|
| Earnings From Continuing Operations | -17.44 | -16.84 | -29.89 | 15.68 | 31.76 | 18.03 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 10.31 | -3.52 | Upgrade
|
| Net Income | -17.44 | -16.84 | -29.89 | 15.68 | 42.07 | 14.52 | Upgrade
|
| Net Income to Common | -17.44 | -16.84 | -29.89 | 15.68 | 42.07 | 14.52 | Upgrade
|
| Net Income Growth | - | - | - | -62.74% | 189.78% | -39.71% | Upgrade
|
| Shares Outstanding (Basic) | 105 | 107 | 115 | 124 | 132 | 140 | Upgrade
|
| Shares Outstanding (Diluted) | 105 | 107 | 115 | 125 | 132 | 140 | Upgrade
|
| Shares Change (YoY) | -7.58% | -6.46% | -7.73% | -5.65% | -5.82% | -2.19% | Upgrade
|
| EPS (Basic) | -0.17 | -0.16 | -0.26 | 0.13 | 0.32 | 0.10 | Upgrade
|
| EPS (Diluted) | -0.17 | -0.16 | -0.26 | 0.13 | 0.32 | 0.10 | Upgrade
|
| EPS Growth | - | - | - | -60.55% | 219.21% | -40.68% | Upgrade
|
| Free Cash Flow | 60.77 | 34.99 | 42.12 | 40.79 | -17.58 | 4.49 | Upgrade
|
| Free Cash Flow Per Share | 0.58 | 0.33 | 0.37 | 0.33 | -0.13 | 0.03 | Upgrade
|
| Gross Margin | 46.23% | 46.51% | 47.03% | 47.40% | 40.94% | 56.72% | Upgrade
|
| Operating Margin | 1.02% | 1.94% | -5.81% | -5.27% | -13.19% | -9.77% | Upgrade
|
| Profit Margin | -5.25% | -5.13% | -10.18% | 6.44% | 21.08% | 30.59% | Upgrade
|
| Free Cash Flow Margin | 18.29% | 10.66% | 14.35% | 16.75% | -8.81% | 9.45% | Upgrade
|
| EBITDA | 49.79 | 53.26 | 40.98 | 32.46 | 2.97 | -0.9 | Upgrade
|
| EBITDA Margin | 14.99% | 16.23% | 13.96% | 13.33% | 1.49% | -1.90% | Upgrade
|
| D&A For EBITDA | 46.39 | 46.89 | 58.04 | 45.29 | 29.28 | 3.73 | Upgrade
|
| EBIT | 3.4 | 6.37 | -17.06 | -12.83 | -26.31 | -4.64 | Upgrade
|
| EBIT Margin | 1.02% | 1.94% | -5.81% | -5.27% | -13.19% | -9.77% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 1.01% | 20.85% | Upgrade
|
Source: S&P Capital IQ. Standard template.